Serum amylase levels are decreased in Chinese non-alcoholic fatty liver disease patients - Wikidata - wikimedia - TriplyDB

Serum amylase levels are decreased in Chinese non-alcoholic fatty liver disease patients

Serum amylase levels are decreased in Chinese non-alcoholic fatty liver disease patients

http://www.wikidata.org/entity/Q34709831

about

Low serum amylase and obesity, diabetes and metabolic syndrome: A novel interpretation Ameliorative effects of lutein on non-alcoholic fatty liver disease in rats Serum Amylase Levels in Relation to Islet β Cell Function in Patients with Early Type 2 Diabetes.Association Between Urinary Alpha1-Microglobulin Levels and Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study.

P2860

Q28066021-E4894DF2-EEEE-495F-8F97-CCE0F251BF17 Q35843044-A7E0A2B3-640F-41B8-A495-1B43BFD09D44 Q36126343-4B8B4945-6B47-4191-A09F-2D6CBE76AE99 Q47195087-5CCB4980-FC49-4D01-88F4-A68D123112FD

P2860

Serum amylase levels are decreased in Chinese non-alcoholic fatty liver disease patients

http://www.wikidata.org/entity/Q34709831

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Serum amylase levels are decreased in Chinese non-alcoholic fatty liver disease patients

@ast

Serum amylase levels are decreased in Chinese non-alcoholic fatty liver disease patients

@en

Serum amylase levels are decreased in Chinese non-alcoholic fatty liver disease patients

@nl

type

label

Serum amylase levels are decreased in Chinese non-alcoholic fatty liver disease patients

@ast

Serum amylase levels are decreased in Chinese non-alcoholic fatty liver disease patients

@en

Serum amylase levels are decreased in Chinese non-alcoholic fatty liver disease patients

@nl

prefLabel

Serum amylase levels are decreased in Chinese non-alcoholic fatty liver disease patients

@ast

Serum amylase levels are decreased in Chinese non-alcoholic fatty liver disease patients

@en

Serum amylase levels are decreased in Chinese non-alcoholic fatty liver disease patients

@nl

P1433

Q34709831-5BC23A5E-98AF-415F-AE38-5D0C52A9F0B0

P1476

Q34709831-BF0C0858-7A12-413F-84E4-189D3AF69467

P2093

Q34709831-033ED311-FB38-4E1D-83EA-DD65CB979263

Q34709831-95DB6C2C-B174-40C6-9092-23479B1062D2

Q34709831-A7C911AD-F61D-4E5F-A840-7FB43B5303F2

Q34709831-B84DFE4B-C3B7-4BA6-8D26-2E4B7BCEE142

Q34709831-F3523D92-7079-4E4F-A4DA-1C9B7FD8A3E3

Q34709831-FEE6CED4-B1BB-4D5D-B08B-FD5E9BE0C3B2

P2860

Q34709831-002CB675-4C52-4DA0-87B3-CE9279B16304

Q34709831-0E844218-D354-4804-82C6-AA1618AE69F5

Q34709831-10648E8F-6D7B-4474-8A52-FC7DA8551901

Q34709831-2F18CA9F-CB30-4D27-8BE4-DC2D1FFDB9AB

Q34709831-3070D7FA-BB13-4357-A87C-AAA30E50A71C

Q34709831-37B2534D-CE48-4AE4-AFAE-FC102B17F797

Q34709831-3D09654E-8229-4ECF-9869-CD64D53520C7

Q34709831-4110C808-366F-4035-9C8B-C94613DF6996

Q34709831-44B95B52-7219-4F4B-BD3D-E60EDCEB7381

Q34709831-4B81C370-037C-4A93-99AE-7DD1D528EAA4

P2888

Q34709831-1F5D17AE-D994-47C5-8E0A-C96A64AF569F

P304

Q34709831-F2252E1C-C8CD-4A5D-A43E-D216B750A83D

P31

Q34709831-7757C04C-25A6-4E13-9D43-741B4EE73FC9

P356

Q34709831-316402EB-DFB1-4967-861C-F01A39018C6B

P478

Q34709831-B9B845B1-2812-4CF8-ADA1-F7F761773420

P577

Q34709831-1F9C2641-B028-440B-8DFC-FF7811921C13

P698

Q34709831-11B95251-3F6E-4F4A-BB76-1B0F8976C1CE

P932

Q34709831-FE2AA7E2-4F1F-41AF-BC91-31F40B97E990

P356

1476-511X-13-185

P1433

Lipids in Health and Disease

P1476

Serum amylase levels are decreased in Chinese non-alcoholic fatty liver disease patients

@en

P2093

Huanle Lu

http://www.w3.org/2001/XMLSchema#string

Jianping Wu

http://www.w3.org/2001/XMLSchema#string

Jinmei Yao

http://www.w3.org/2001/XMLSchema#string

Juanwen Zhang

http://www.w3.org/2001/XMLSchema#string

Yani Hong

http://www.w3.org/2001/XMLSchema#string

Ying Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

From NAFLD in clinical practice to answers from guidelines

A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches

NIKEI: a new inexpensive and non-invasive scoring system to exclude advanced fibrosis in patients with NAFLD

Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?

Non-alcoholic fatty liver disease: epidemiology, clinical course, investigation, and treatment.

Elevated red cell distribution width is associated with advanced fibrosis in NAFLD.

The burden of liver disease in Europe: a review of available epidemiological data.

P2888

1476-511x-13-185

P304

185

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1476-511X-13-185

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25481429

http://www.w3.org/2001/XMLSchema#string

P932

4267431

http://www.w3.org/2001/XMLSchema#string